Fresenius Medical Care AG
FMS
$22.09
-$0.02-0.07%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.09B | 1.12B | 807.38M | 720.31M | 665.95M |
| Total Depreciation and Amortization | 1.58B | 1.58B | 1.59B | 1.58B | 1.59B |
| Total Amortization of Deferred Charges | 73.61M | 73.61M | 56.17M | 56.17M | 56.17M |
| Total Other Non-Cash Items | 234.31M | 118.83M | 97.16M | -74.41M | -227.89M |
| Change in Net Operating Assets | 190.47M | 196.17M | 249.73M | 733.70M | 536.07M |
| Cash from Operations | 3.17B | 3.08B | 2.80B | 3.02B | 2.62B |
| Capital Expenditure | -1.11B | -1.05B | -809.89M | -766.95M | -763.33M |
| Sale of Property, Plant, and Equipment | 18.70M | 18.82M | 21.04M | 16.06M | 13.91M |
| Cash Acquisitions | -15.66M | -16.86M | -1.25M | -11.55M | -8.19M |
| Divestitures | 215.74M | 233.89M | 325.10M | 158.45M | 653.71M |
| Other Investing Activities | -14.02M | -15.22M | -324.60K | -39.98M | -31.67M |
| Cash from Investing | -905.71M | -825.13M | -465.32M | -643.97M | -135.58M |
| Total Debt Issued | 1.85B | 1.78B | 1.20B | 1.14B | -44.56M |
| Total Debt Repaid | -1.63B | -1.63B | -2.18B | -1.90B | -1.72B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -932.62M | -585.29M | -151.12M | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -479.52M | -479.52M | -479.52M | -479.52M | -375.82M |
| Other Financing Activities | -557.66M | -544.99M | -612.33M | -320.22M | -299.85M |
| Cash from Financing | -1.98B | -1.63B | -2.41B | -1.61B | -2.60B |
| Foreign Exchange rate Adjustments | -115.13M | -160.21M | -68.61M | -63.24M | 8.64M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 171.69M | 472.57M | -141.79M | 703.27M | -110.96M |